View Lymphoma Overview Page

Viral Lymphoma

The Lymphoma Channel on VJHemOnc is supported by Janssen Pharmaceuticals (a Johnson & Johnson Company), Takeda and Karyopharm Therapeutics. The companies have no influence over the production of the content.

Viral Lymphoma

The Lymphoma Channel on VJHemOnc is supported by Janssen Pharmaceuticals (a Johnson & Johnson Company), Takeda and Karyopharm Therapeutics. The companies have no influence over the production of the content.
Oral nanatinostat and valganciclovir for EBV-associated lymphomas 1:47
Oral nanatinostat and valganciclovir for EBV-associated lymphomas
Pierluigi Porcu
Dutch HOVON lymphoma study group update 2:36
Dutch HOVON lymphoma study group update
Pieternella Lugtenburg • 20 Jun 2019
Viral lymphomas: risk factors and treatments 8:24
Viral lymphomas: risk factors and treatments
Catherine Bollard et al. • 21 Sep 2018
Cellular therapy and drug access for viral lymphomas 9:57
Cellular therapy and drug access for viral lymphomas
Catherine Bollard et al. • 21 Sep 2018
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals